Jan 1, 2025, 06:18
Amil Druzic: The significant efficacy of FOLFIRINOX in metastatic pancreatic cancer in a real-world setting
Amil Druzic, Oncology and Radiotherapy Resident at Clinical center University of Sarajevo, shared a post on LinkedIn:
“Our new study, published in Sarajevo Medical Journal demonstrates the significant efficacy of FOLFIRINOX in treating metastatic pancreatic cancer in a real-world setting. Personalized approaches, including genetic profiling, microbiome analysis, and AI integration, offer promising avenues to enhance treatment outcomes and improve quality of life for patients.”
Enhanced Survival Outcomes with FOLFIRINOX in Initial Metastatic Pancreatic Cancer: Single-Center
Authors: Emir Sokolovic et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 1, 2025, 06:02
Dec 31, 2024, 17:57
Dec 31, 2024, 11:53
Dec 31, 2024, 11:16
Dec 31, 2024, 11:03
Dec 31, 2024, 10:54
Dec 31, 2024, 10:28
Dec 31, 2024, 10:13
Dec 31, 2024, 09:57